Bank of New York Mellon »

Rigel Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $737k 46k 16.18
2024-06-30 $489k 60k 8.22

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Inc - A Cl A (MA)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Bank of New York Mellon

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Morgan Stanley
Invesco
Soleus Capital Management
Vanguard Group
Susquehanna International
Assenagon Asset Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
CM Management
Ing Investment Management

View all funds holding Rigel Pharmaceuticals